Lv21
110 积分 2024-07-06 加入
Novel therapies for myasthenia gravis: translational research from animal models to clinical application
2天前
已关闭
Efgartigimod improves non-AChR generalized Myasthenia Gravis: a real world experience
5天前
已完结
Insights from transgenic mouse models of ERBB2-induced breast cancer
1个月前
已完结
Induction cyclophosphamide with maintenance immunosuppression in high-risk myasthenia gravis: long-term follow-up and safety profile
8个月前
已完结
皖公网安备34019202002308
